Cannabis-induced attenuated psychotic symptoms: Implications for prognosis in young people at ultra-high risk for psychosis

M. J. McHugh, P.D. Mcgorry, A.R. Yung, A. Lin, Sharren Wood, J.A. Hartmann, B. Nelson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS). Method Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years). Results A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS. Conclusions Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.

Original languageEnglish
Pages (from-to)616-626
Number of pages11
JournalPsychological Medicine
Volume47
Issue number4
DOIs
Publication statusPublished - 1 Mar 2017

Fingerprint

Cannabis
Psychotic Disorders
Marijuana Abuse
Confidence Intervals

Cite this

McHugh, M. J. ; Mcgorry, P.D. ; Yung, A.R. ; Lin, A. ; Wood, Sharren ; Hartmann, J.A. ; Nelson, B. / Cannabis-induced attenuated psychotic symptoms : Implications for prognosis in young people at ultra-high risk for psychosis. In: Psychological Medicine. 2017 ; Vol. 47, No. 4. pp. 616-626.
@article{f6822fd614574d008f67494474723ccc,
title = "Cannabis-induced attenuated psychotic symptoms: Implications for prognosis in young people at ultra-high risk for psychosis",
abstract = "Background Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS). Method Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years). Results A history of cannabis abuse was reported in 58{\%} of the sample. Of these, 26{\%} reported a history of cannabis-induced APS. These individuals were 4.90 (95{\%} confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS. Conclusions Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.",
keywords = "Cannabis, psychosis, ultra-high risk",
author = "McHugh, {M. J.} and P.D. Mcgorry and A.R. Yung and A. Lin and Sharren Wood and J.A. Hartmann and B. Nelson",
year = "2017",
month = "3",
day = "1",
doi = "10.1017/S0033291716002671",
language = "English",
volume = "47",
pages = "616--626",
journal = "Psychological Medicine.",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "4",

}

Cannabis-induced attenuated psychotic symptoms : Implications for prognosis in young people at ultra-high risk for psychosis. / McHugh, M. J.; Mcgorry, P.D.; Yung, A.R.; Lin, A.; Wood, Sharren; Hartmann, J.A.; Nelson, B.

In: Psychological Medicine, Vol. 47, No. 4, 01.03.2017, p. 616-626.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cannabis-induced attenuated psychotic symptoms

T2 - Implications for prognosis in young people at ultra-high risk for psychosis

AU - McHugh, M. J.

AU - Mcgorry, P.D.

AU - Yung, A.R.

AU - Lin, A.

AU - Wood, Sharren

AU - Hartmann, J.A.

AU - Nelson, B.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS). Method Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years). Results A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS. Conclusions Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.

AB - Background Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS). Method Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years). Results A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS. Conclusions Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.

KW - Cannabis

KW - psychosis

KW - ultra-high risk

UR - http://www.scopus.com/inward/record.url?scp=84994615759&partnerID=8YFLogxK

U2 - 10.1017/S0033291716002671

DO - 10.1017/S0033291716002671

M3 - Article

VL - 47

SP - 616

EP - 626

JO - Psychological Medicine.

JF - Psychological Medicine.

SN - 0033-2917

IS - 4

ER -